BIOSPAIN 2026

Dr. Bueren leads the Biomedical Innovation Unit at CIEMAT and also conducts research at CIBERER and the Jiménez Díaz Foundation Health Research Institute. Throughout his career, he has made decisive contributions to the development of new gene and cell therapies targeting rare and hereditary diseases, driving the translation of research from the laboratory to clinical practice.

Internationally recognized for his scientific contributions and leadership in the field of gene therapy, he has also served as president of the European Society for Gene and Cell Therapy, promoting the advancement and accessibility of these innovative therapies for patients.

At BIOSPAIN, he will will share an updated perspective on the advances transforming the treatment of rare diseases, as well as the scientific, regulatory, and access challenges that still need to be overcome to ensure these therapies reach all patients who need them.